Or call 888-224-2480 for fastest service.

You can save extra 10% off the current rate by using code D10-999-JDS23.

Hosted by American Conference Institute (ACI), the National Forum on IP, Funding and Tech Strategies for Novel Therapeutic Modalities and Gene Therapies will highlight leveraging technology, safeguarding IP, and securing funding to accelerate development in mRNA, CRISPR and CAR-T.

ACI is delighted to bring you this new program, which is a holistic, end-to-end summit for therapeutic pioneers, innovators, investors, executives and their counsel to meet, assess, and shape the future development and commercialization of these novel modalities and therapies.

CONFERENCE CO-CHAIRS

We are pleased to announce that representatives from the USPTO and FDA, as well as, distinguished in-house and outside counsel, will present at this groundbreaking event to discuss IP and regulatory initiatives that are essential to the proliferation of these therapeutics.

GOVERNMENT SPEAKERS

Critical sessions will cover:

• What Every Life Sciences Business Executive and Counsel Need to Know about the mRNA and CRISPR Patent War
• Assessing Competitors, Mapping Opportunities, and Mastering the IP Due Diligence Process
• Best practices for Securing Financing and Capital Formation
• Leveraging the Power of AI, ML, Automation and Data for the Development of Better Medicines

Save 10% off the current registration fee by using code D10-999-JDS23.

*Discount is valid for new registrations only and it’s not applicable for workshops.